Status:
UNKNOWN
Neurofunctional Correlates of the Behavioral Modifications Associated With Tachidino in Children With Developmental Dyslexia
Lead Sponsor:
IRCCS Eugenio Medea
Conditions:
Dyslexia, Developmental
Eligibility:
All Genders
8-12 years
Phase:
NA
Brief Summary
Developmental dyslexia (DD) is the most common learning disorder. Multiple cognitive and sensory domains contribute to the etiology of DD and develop before reading acquisition. Atypical brain functio...
Eligibility Criteria
Inclusion
- Reading skills (both accuracy and speed) below -2.00 standard deviation
Exclusion
- No ADHD
- No contraindications to magnetic resonance
Key Trial Info
Start Date :
January 2 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05373576
Start Date
January 2 2022
End Date
December 31 2023
Last Update
May 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Scientific Institute IRCCS Eugenio Medea
Bosisio Parini, LC, Italy, 23842